en

PRODUCT DETAIL

Briumvi 150 mg koncentrát na infúzny roztok

Code 3942E
MA number EU/1/23/1730/001
Product Form: con inf 1x6 ml/150 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AG ?
L04AG14 Ublituximab
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 31.05.2023
Validity: 31.05.2028
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 26.07.2023
eu-flag.png sk-flag.png